Palisade Bio, Inc. · NASDAQ:PALI
Commodore Capital LP reported a 9.90% stake in Palisade Bio, Inc. (Schedule 13G)
Event Oct 1, 2025 · Filed Oct 8, 2025
Commodore Capital LP reported a 9.90% stake in Palisade Bio, Inc., 9,690,665 shares, as a passive investor on Oct 1, 2025. Filed Oct 8, 2025 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 9,690,665
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 9.90% | 9,690,665 |
| Commodore Capital Master LP | 9.90% | 9,690,665 |
| Robert Egen Atkinson | 9.90% | 9,690,665 |
| Michael Kramarz | 9.90% | 9,690,665 |
Source
Related
- Palisade Bio, Inc.
- Commodore Capital LP
- Palisade Bio, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · May 15, 2026
- Form 4 · Finley John David · Oct 7, 2026
- Form 4 · Jones Mitchell Lawrence · Oct 7, 2026
- Form 4 · Williams Donald Allen · Oct 5, 2026
- Form 4 · Finley John David · Aug 21, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026